Pulmonary safety of Staccato®alprazolam in healthy participants and participants with mild asthma: phase 1, randomised, double-blind, placebo-controlled trial

Important Information Related to Your Request:

STACCATO^® alprazolam is an investigational product currently in clinical development and has not received approval from any regulatory authority worldwide. The material below is provided in response to your specific search for information on UCBCOMPASS^®. It is not intended to advocate any indication, dosage, or other claim, or to draw any conclusions regarding the safety and efficacy of STACCATO^® alprazolam.

This material is not for distribution or reproduction.